Replies to post #204285 on Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Pfizer's recent AdComm was for their extended release product. People are misconstruing the facts. SequestOx IS an immediate release product.

Right. Remember the KemPharm AdComm KP201/APAP vote. As an immediate-release opioid, they first voted on approval and then just "abuse deterrent labeling." The vote was not broken down into IV, nasal, oral. The entire ADF vote was about nasal abuse. As I said before, the FDA does not believe IR drugs are IV abused, and the oral abuse question is moot in reference to immediate-release drugs. Unfortunately for KemPharm investors, their nasal pharmacokinetics is what sunk them.